BiotechFrance

In the wake of the 2025 Nobel Prize in Physiology or Medicine, FoxBio is accelerating the clinical translation of CAR-Tregs to treat severe, disabling chronic inflammatory diseases. A €35M fundraising round is underway. Behind FoxBio, founded on Mar